BIOQBIOQ
LOADING
|||
BIOQ Revenue Growth (YoY Quarterly)•-16.27%
SAPRO
Growth Metrics
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -24.45% | -28.19% | -8.54% | -1.10% | -16.27% |
| Gross Profit Growth | -85.54% | -104.48% | +16.42% | +0.00% | +100.24% |
| EBITDA Growth | -76.15% | -193.83% | +85.04% | +0.00% | +84.50% |
| Operating Income Growth | -196.95% | -423.50% | +384.92% | +0.00% | +0.00% |
| Net Income Growth | -175.08% | -350.11% | +240.34% | +0.00% | +0.00% |
| EPS Growth | -175.25% | -351.85% | +238.71% | +0.00% | +0.00% |
| EPS Diluted Growth | -174.26% | -351.85% | +238.71% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -0.65% | -0.35% | +0.00% | -1.76% | +0.66% |
| Weighted Average Shares Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -148.48% | -85.29% | +56.85% | +0.00% |
| Free Cash Flow Growth | +0.00% | -150.86% | -84.63% | +63.67% | +0.00% |
| Receivables Growth | -38.47% | -15.96% | -10.39% | -5.99% | -18.14% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -12.45% | -2.15% | -4.87% | +0.94% | +1.49% |
| Book Value per Share Growth | -3.36% | -8.07% | -6.63% | -2.25% | -3.52% |
| Debt Growth | -21.82% | +8.37% | +10.77% | +361.13% | +12.34% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -15.50% | -13.58% | -25.93% | +219.54% | -11.12% |
1 / 4